In the BioHarmony Drug Report Database
Prezista (darunavir) is a small molecule pharmaceutical. Darunavir was first approved as Prezista on 2006-06-23. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Prezista’s patent is valid until 2026-12-26 (FDA).
Image (chem structure or protein)